Known targets — ChEMBL curated mechanism
CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1
The experimentally established mechanism targets of Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.80 |
| ▸ | FAAH | O00519 | 8/20 | 0.53 |
| ▸ | NAAA | Q02083 | 1/20 | 0.51 |
| ▸ | CASP2 | P42575 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.49 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | SELP | P16109 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lactic Acid SCHEMBL3336829 | 1.00 | DNM1 (0.80) | DNM1FAAHNAAACASP2EPHX2 | |
| Lactic Acid SCHEMBL3863099 | 1.00 | DNM1 (0.80) | DNM1FAAHNAAACASP2EPHX2 | |
| Lactic Acid SCHEMBL428727 | 1.00 | DNM1 (0.80) | DNM1FAAHNAAACASP2EPHX2 | |
| Lactic Acid SCHEMBL25266814 | 0.93 | DNM1 (0.79) | DNM1FAAHNAAACASP2EPHX2 | |
| Lactic Acid SCHEMBL432082 | 0.92 | DNM1 (0.68) | DNM1FAAHEPHX2KDM4EMEN1 | |
| Lactic Acid SCHEMBL28053597 | 0.92 | DNM1 (0.68) | DNM1FAAHEPHX2KDM4EMEN1 | |
| SCHEMBL8660980 | 0.89 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL5383341 | 0.89 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL9565176 | 0.89 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL19281112 | 0.89 | DNM1 (1.00) | DNM1FAAHNAAACASP2EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260055056-A1 | ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE | WILLIAM M YARBROUGH FOUND (US) | 2026-02-26 | — | — | US | claimed |
| US-12310939-B2 | Method for treating rheumatoid arthritis | THE WILLIAM YARBROUGH FOUNDATION (US) | 2025-05-27 | — | — | US | claimed |
| US-20250161258-A1 | ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE | THE WILLIAM M YARBROUGH FOUND (US) | 2025-05-22 | — | — | US | claimed |
| CN-119139157-B | Hair loss preventing and caring component, preparation method thereof and shampoo | 广州市圣莎拉化妆品有限公司 | 2025-03-07 | — | — | CN | claimed |
| US-12239626-B2 | Method for treating infectious diseases with isothiocyanate functional compounds | THE WILLIAM YARBROUGH FOUNDATION (US) | 2025-03-04 | — | — | US | claimed |
| US-12178795-B2 | Method for treating metastatic prostate cancer | THE WILLIAM YARBROUGH FOUNDATION (US) | 2024-12-31 | — | — | US | claimed |
| CN-119139157-A | Hair loss preventing and caring component, preparation method thereof and shampoo | 广州市圣莎拉化妆品有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-110180340-B | Low-temperature plasma waste gas treatment device | 齐齐哈尔龙江阜丰生物科技有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-118615207-A | Refreshing type children's foam shampoo and preparation method thereof | 福建省梦娇兰日用化学品有限公司 | 2024-09-10 | — | — | CN | claimed |
| CN-116158986-B | Hair cationic conditioner with fluffy effect | 佛山合德新材料有限公司 | 2023-11-28 | — | — | CN | claimed |
| EP-1765260-A2 | SANITIZING COMPOSITION AND METHOD OF PREPARATION | Brown, Steven J. (US) | 2007-03-28 | — | — | EP | claimed |
| WO-2006085907-A2 | SANITIZING COMPOSITION AND METHOD OF PREPARATION | BROWN STEVEN J (US) | 2006-08-17 | — | — | WO | claimed |
| US-20050271595-A1 | Sanitizing composition and method of preparation | BROWN JAMES S | 2005-12-08 | — | — | US | claimed |
| US-20020155962-A1 | Nonaqueous hair styling composition and method of use | ANDREW JERGENS COMPANY, THE | 2002-10-24 | — | — | US | claimed |
| US-5948416-A | LEAVE ON SKIN CARE COMPOSITION; HYDROPHOBIC STRUCTURING AGENT; HYDROPHILIC CATIONIC SURFACTANT; ACTIVE COMPOUND | THE PROCTER & GAMBLE COMPANY (US) | 1999-09-07 | — | — | US | claimed |
| US-5437809-A | Shampoo compositions with dimethicone copolyols | THE GILLETTE COMPANY (US) | 1995-08-01 | — | — | US | claimed |
| EP-0563330-A1 | SHAMPOO COMPOSITIONS | THE GILLETTE COMPANY (US) | 1993-10-06 | — | — | EP | claimed |
| WO-1992010990-A1 | SHAMPOO COMPOSITIONS | THE GILLETTE COMPANY (US) | 1992-07-09 | — | — | WO | claimed |
| EP-0410659-A2 | Method and composition to impart improved conditioning properties to the hair | HELENE CURTIS, INC. (US) | 1991-01-30 | — | — | EP | claimed |
| US-4976956-A | Water soluble and oil soluble quaternary ammonium compounds and amidoamine | HELENE CURTIS, INC. (US) | 1990-12-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260055056-A1 | ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE | ALK, C9, MSR1 | DNM1 4860/4885FAAH 1590/4885NAAA 1522/4885 |
| US-12178795-B2 | Method for treating metastatic prostate cancer | BPHL, KLK3, ACP3 | DNM1 3577/4885FAAH 1303/4885NAAA 532/4885 |
| US-12239626-B2 | Method for treating infectious diseases with isothiocyanate functional compounds | CFTR, TST, ICMT | DNM1 3945/4885FAAH 2592/4885NAAA 394/4885 |
| US-12310939-B2 | Method for treating rheumatoid arthritis | MIF, TNF, MMP12 | DNM1 3267/4885FAAH 1121/4885NAAA 1566/4885 |
| US-20250161258-A1 | ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE | TST, TMSB10, NHERF1 | DNM1 3740/4885FAAH 3558/4885NAAA 1765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.